Active

KATALYST Life Sciences

Switched

BE0760501477

Rechtspersoon Private limited company 1 establishment

Rue Strivay(PLX) 112, 4122 Neupré Speur- en ontwikkelingswerk op biotechnologisch gebied

Active for

5 year, 8 months

Financials

Financial year 2025

Gross margin

€ -4,856

▼ 107% vs 2024

Profit

Caution

€ -6,729

▼ 112% vs 2024

Debts

Low

€ 3,091

▼ 94% vs 2024

KATALYST Life Sciences from Neupré, company number BE0760501477, closed financial year 2025 with a result of € -6,729 after tax. For that financial year KATALYST Life Sciences recorded a gross margin of € -4,856 and equity of € 317,784. Compared with financial year 2024, the result moved from € 53,914 to € -6,729. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 18, 2026.

What happened at KATALYST Life Sciences?

What happened at KATALYST Life Sciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 6,729 (▼ 112% vs 2024). filed late Source: NBB ↗
  • New establishment in Neupré. KBO
  • Carine Goraj became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 79,305 profit in 2021 to € 6,729 loss in 2025.

Paid € 150,506 in corporate taxes since 2021.

Best year ever: 2023, with € 131,797 profit.

Paid out € 45,000 in dividends to the owners in total.

A new publication or filing at KATALYST Life Sciences? We notify you, reason included.

Follow KATALYST Life Sciences

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Carine Goraj
KATALYST Life Sciences

Behind KATALYST Life Sciences is Carine Goraj. Carine Goraj is also behind RENTALIS and BLCK-INVEST.

See the full network in the app

Directors

According to the 2025 annual accounts

Carine Goraj

Director

Also active at: RENTALIS, BLCK-INVEST

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Strivay(PLX) 112

4122 Neupré

2.313.040.521

Route de Bonsgnée(RR) 145

4120 Neupré

Active since 1 January 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

Details

Company number
0760.501.477
VAT number
BE 0760.501.477
Registered office
Rue Strivay(PLX) 112, 4122 Neupré
Names & denominations
KATALYST Life Sciences
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
23 December 2020
Peppol
Active · Active since 14 Oct 2025
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Frequently asked questions

What is the enterprise number of KATALYST Life Sciences?
The enterprise number of KATALYST Life Sciences is BE0760501477.
What is the address of KATALYST Life Sciences?
The registered office of KATALYST Life Sciences is located at Rue Strivay(PLX) 112, 4122 Neupré.
When was KATALYST Life Sciences founded?
KATALYST Life Sciences was founded on 23 December 2020.
What is the main activity of KATALYST Life Sciences?
The main activity of KATALYST Life Sciences is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does KATALYST Life Sciences have a website?
No website is currently known for KATALYST Life Sciences.
How much profit did KATALYST Life Sciences make in 2025?
KATALYST Life Sciences recorded a loss after taxes of € 6,729 in financial year 2025.
What is the revenue of KATALYST Life Sciences?
As a small company, KATALYST Life Sciences is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -4,856.
Where can I find the annual accounts of KATALYST Life Sciences?
KATALYST Life Sciences files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of KATALYST Life Sciences?
According to the 2025 annual accounts, the directors of KATALYST Life Sciences are: Carine Goraj.
Who owns KATALYST Life Sciences?
Behind KATALYST Life Sciences is Carine Goraj. Carine Goraj is also behind RENTALIS and BLCK-INVEST.